Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 2 |
Descriptor
| Alzheimers Disease | 2 |
| Patients | 2 |
| Aging (Individuals) | 1 |
| Attitudes | 1 |
| Caregivers | 1 |
| Cognitive Ability | 1 |
| Decision Making | 1 |
| Disabilities | 1 |
| Drug Therapy | 1 |
| Models | 1 |
| Older Adults | 1 |
| More ▼ | |
Source
| Canadian Journal on Aging | 2 |
Author
| Bankes, Jane | 1 |
| Bergman, Howard | 1 |
| Oremus, Mark | 1 |
| Slaughter, Susan | 1 |
| Vandal, Alain C. | 1 |
| Wolfson, Christina | 1 |
Publication Type
| Journal Articles | 2 |
| Reports - Descriptive | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkOremus, Mark; Wolfson, Christina; Bergman, Howard; Vandal, Alain C. – Canadian Journal on Aging, 2007
Physicians (N=803) were contacted via postal survey and given two sets of efficacy measures for drug treatments in Alzheimer's disease: (a) the time that patients spend in a mild or moderate state of disease; (b) levels of modification to disease progression in the areas of cognition, behaviour, and mood, and ability to perform basic activities of…
Descriptors: Patients, Physicians, Alzheimers Disease, Surveys
Slaughter, Susan; Bankes, Jane – Canadian Journal on Aging, 2007
The Functional Transitions Model (FTM) integrates the theoretical notions of progressive functional decline associated with Alzheimer's disease (AD), excess disability, and transitions occurring intermittently along the trajectory of functional decline. Application of the Functional Transitions Model to clinical practice encompasses the paradox of…
Descriptors: Patients, Caregivers, Alzheimers Disease, Older Adults
